Physician profile
Luke Wang
NPI 1033630173
$1,461.98
in general payments reported to CMS, 2019-2025
12 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2023: $463 · 2024: $353 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $311.54 | 2024-2025 | Cvac Aspiration System |
| Intuitive Surgical, INC. | $218.01 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $154.80 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals Lp | $152.40 | 2023 | Lynparza |
| Biotissue Holdings INC. | $146.62 | 2023 | |
| Boston Scientific Corporation | $140.35 | 2021 | |
| Merck Sharp & Dohme LLC | $100.60 | 2023 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $82.92 | 2021 | |
| Teleflex LLC | $75.12 | 2025 | Deflux Metal Needle |
| Myriad Genetic Laboratories, INC. | $35.66 | 2023 | Myrisk |
| Cycle Pharmaceuticals INC | $23.35 | 2025 | Venxxiva |
| Procept Biorobotics Corporation | $20.61 | 2024 | Aquabeam System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.